LIC MF Healthcare Fund Direct IDCW
NAV ₹38.5507 on 13 November 2026
AMFI name: LIC MF Healthcare Fund-Direct Plan-IDCW · Scheme code 152023
IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY HEALTHCARE INDEX TRI | Category median |
|---|---|---|---|
| 1M | +9.13% | +8.67% | +5.71% |
| 6M | +13.03% | +12.84% | +7.79% |
| 1Y | +17.47% | +38.92% | +4.11% |
| 3Y | +21.92% | +28.05% | +14.35% |
| 5Y | - | - | +12.25% |
Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare - TRI, which we do not hold, so this is the closest NSE index.
Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.
Rank among peers
Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #- | LIC MF Healthcare FundCurrent Fund LIC Mutual Fund | +21.92% | +17.47% | - | 1.13% | ₹99 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 1.13% · Regular 2.44%
- Exit load
- Nil, If units of the Scheme are redeemed or switched out up to 12% of the units (the limit) within 90 days from the date of allotment. 1% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.
- Fund size (all plans)
- ₹99 CrAverage, quarter to September 2026
- Benchmark
- BSE Healthcare - TRICompared here with NIFTY HEALTHCARE INDEX TRI
- Launch date
- 8 February 2019AMFI
- Type
- An open-ended equity scheme investing in Healthcare and Allied sectors
- AMFI scheme code
- 152023
Fund managers (2)
- Sudhanshu Asthana
- Dhaval Sangoi
How each manager has done since taking over: fund manager scorecard.
Investment objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.
About this fund
LIC MF Healthcare Fund Direct IDCW is a mutual fund scheme from LIC Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the IDCW option. Its NAV was ₹38.5507 on 13 November 2026. Its NAV changed by 17.47% over 1 year and 21.92% a year over 3 years. These figures leave out IDCW payouts, so they understate what investors received. Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 28.05% a year over 3 years. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹99 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.13% a year for the Direct plan. Managed by Sudhanshu Asthana and Dhaval Sangoi. AMFI lists the scheme's launch date as 8 February 2019.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.
Plans and options of this fund (6)
| Plan | Option | ISIN | AMFI code | NAV |
|---|---|---|---|---|
| DirectThis page | IDCW | INF397L01LD9 | 152023 | ₹38.5513 Nov 2026 |
| Direct | Growth | INF397L01LG2 | 152024 | ₹38.5613 Nov 2026 |
| Direct | Growth | INF397L01LG2 | 152024 | ₹34.7313 Nov 2026 |
| Regular | Growth | - | 152025 | ₹34.7313 Nov 2026 |
| Regular | IDCW | INF397L01LK4 | 152026 | ₹38.5613 Nov 2026 |
| Regular | IDCW | INF397L01LK4 | 152026 | ₹34.7313 Nov 2026 |